Drug concentration at the site of disease in children with pulmonary tuberculosis

BACKGROUND: Current TB treatment for children is not optimized to provide adequate drug levels in TB lesions. Dose optimization of first-line antituberculosis drugs to increase exposure at the site of disease could facilitate more optimal treatment and future treatment-shortening strategies across t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Varela, Elisa, Abulfathi, Ahmed A., Strydom, Natasha, Goussard, Pierre, van Wyk, Abraham C., Demers, Anne Marie, Deventer, Anneen Van, Garcia-Prats, Anthony J., van der Merwe, Johannes, Zimmerman, Matthew, Carter, Claire L., Janson, Jacques, Morrison, Julie, Reuter, Helmuth, Decloedt, Eric H., Seddon, James A., Svensson, Elin M., Warren, Rob, Savic, Radojka M., Dartois, Véronique, Hesseling, Anneke C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155609/
https://www.ncbi.nlm.nih.gov/pubmed/35468189
http://dx.doi.org/10.1093/jac/dkac103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155609/
https://www.ncbi.nlm.nih.gov/pubmed/35468189
http://dx.doi.org/10.1093/jac/dkac103

Ejemplares similares